Federal Register / Vol. 62, No. 248 / Monday, December 29, 1997 / Notices 67683

symbol ‘‘L’’ in the parentheses following the

‘‘Free’’ rate of duty in such subcolumn.

(b) In the additional U.S. notes to HTS

section XI listed below, the expression

‘‘articles the product of Canada’’ is deleted at

each instance and the expression ‘‘Imports

from Canada’’ is inserted in lieu thereof.

additional U.S. note 3(a); additional U.S. note

4(c)

additional U.S. note 3(f); additional U.S. note

5(a)

additional U.S. note 4(a); additional U.S. note

5(c)

(c) In the additional U.S. notes to HTS

section XI listed below, the expression

‘‘articles the product of Mexico’’ is deleted at

each instance and the expression ‘‘imports

from Mexico’’ is inserted in lieu thereof.

additional U.S. note 3(b); additional U.S.

note 4(b)

additional U.S. note 3(c); additional U.S. note

4(d)

additional U.S. note 3(d); additional U.S.

note 5(b)

additional U.S. note 3(e); additional U.S. note

5(d)

additional U.S. note 3(g)

(d) The article description for HTS heading

9817.29.01 is modified by deleting

‘‘3701.90.32’’ and by inserting in lieu thereof

‘‘3707.90.32’’.

(e) The Intermediate Chemicals for Dyes

Appendix to the HTS is modified by deleting

the chemical name ‘‘Banzamine, 2, 6–

dichloro–4–nitro’’ and by inserting

‘‘Benzamine, 2, 6–dichloro–4–nitro’’ in lieu

thereof, and by deleting the chemical name

‘‘Benzeneamine, 2–(triflouromethyl)–’’ and

by inserting ‘‘Benzeneamine, 2–

(triflouromethyl)–’’ in lieu thereof.

3. Effective on January 1, 1996, the HTS is

modified as follows:

(a) The tariff classification rules (‘‘TCRs’’)

in subdivision (t) of general note 12 to the

HTS are modified by deleting from chapter

rule 1 to chapter 61 and from chapter rule 1

to chapter 62 the subheading number

‘‘5407.60’’ and by inserting in lieu thereof

‘‘5407.61’’.

(b) The article description for HTS

subheading 6303.92.10 is modified by

deleting ‘‘5407.60.11, 5407.60.21 or

5407.60.91’’ and by inserting in lieu thereof

‘‘5407.61.11, 5407.61.21 or 5407.61.91’’.

(c) The article description for HTS

subheading 9017.20.50 is modified by

deleting ‘‘8456.90.20’’ and by inserting in

lieu thereof ‘‘8456.99.10’’.

(d) U.S. note 3(d) to subchapter II of

chapter 98 is modified by deleting

‘‘additional U.S. note 1’’ and inserting ‘‘note

3’’ in lieu thereof.

4. Effective April 1, 1997, for subheading

2933.59.95, the Rates of Duty 1—special

subcolumn is modified by inserting, in

alphabetical sequence, the symbol ‘‘K’’ in the

parentheses following the ‘‘Free’’ rate of duty

in such subcolumn.

5. Effective April 28, 1997, general note 12

to the HTS is modified as follows:

(a) by numbering the tariff classification

rule to chapter 82 that reads ‘‘A change to

subheadings 8202.39 through 8202.99 from

any other chapter.’’ as TCR 4 to that chapter;

(b) by modifying TCR 231 for chapter 84

by deleting ‘‘tariff items,’’ and by inserting in

lieu thereof ‘‘tariff item, ‘‘; and

(c) by deleting from TCR 90 for chapter 85

‘‘8428.12.62’’ and by inserting in lieu thereof

‘‘8528.12.62’’.

6. Effective May 31, 1997:

(a) For HTS subheading 0802.90.98, the

Rates of Duty 1—Special subcolumn is

modified by inserting, immediately before

the symbol ‘‘CA’’ in parentheses, the symbol

‘‘A+,’’; and

(b) Section (c) to Annex II to Presidential

Proclamation 7007 is modified by deleting

HTS subheadings 0802.90.90, 2901.29.50,

8607.19.03, 9603.10.50 and 9603.10.60.

7. Effective July 1, 1997, section B of

Annex I to Presidential Proclamation 7011 of

June 30, 1997, is modified by deleting the

text of paragraph (68) and by inserting in lieu

thereof the following: ‘Heading 9902.84.77 is

modified by deleting ‘‘8477.10.80’’ and by

inserting in lieu thereof ‘‘8477.10.70’’.’

8. Effective on the date of publication of

this notice in the Federal Register, section

A(5) of Annex II to Presidential Proclamation

6969 is modified as follows:

(a) by deleting, from subparagraph (a) of

such section, the expression ‘‘April 1, 1998,

through March 31, 1999, inclusive’’ and by

inserting ‘‘April 1 in any year through March

31, inclusive’’ in lieu thereof; and

(b) by deleting, from subparagraph (b) of

such section, the expression ‘‘April 1, 1999,

through March 31, 2000, inclusive’’ and by

inserting ‘‘April 1, 2000, through March 31,

2001, inclusive’’ in lieu thereof.

9. Effective January 1, 1998:

(a) Section D of the Annex to Proclamation

6763 is modified by striking from the column

headed ‘‘1998’’ for subheading 2620.90.20

the duty rate of ‘‘18.5¢/kg on tungsten

content + 4%’’ and by inserting the duty rate

‘‘17.6¢/kg on tungsten content + 4%’’ in lieu

thereof; and

(b) Subheading 8529.90.88 is modified by

striking from the ‘‘Special’’ rates of duty

subcolumn the rate ‘‘0.5% (CA)’’ and by

inserting in alphabetical sequence in the

parenthetical expression following the duty

rate of ‘‘Free’’ in such subcolumn the symbol

‘‘CA,’’.

(c) General note 3(iv)(C) is modified by

deleting ‘‘sections 503(b) and 504(c) and by

inserting ‘‘sections 503(a)(2), 503(a)(3) and

503(c)’’ in lieu thereof.

(d) General note 4(a) is modified by

deleting ‘‘section 502(a)(3) of the Trade Act

of 1974 (19 U.S.C. 2462(a)(3)’’ and by

inserting ‘‘section 507(2) of the Trade Act of

1974 (19 U.S.C. 2467(2)’’ in lieu thereof.

(e) General note 4(b)(i) is modified by

deleting ‘‘section 504(c)(6)’’ and by inserting

‘‘section 502(a)(2)’’ in lieu thereof, by

deleting ‘‘section 504(c)’’ and by inserting

‘‘section 503(c)(2)(A)’’ in lieu thereof, and by

deleting ‘‘19 U.S.C. 2464(c)’’ and by inserting

‘‘19 U.S.C. 2463(c)(2)(A)’’ in lieu thereof.

(f) The last paragraph of general note 4(c)

is modified by deleting ‘‘section 503(a)(3)’’

and by inserting ‘‘section 507(2)’’ in lieu

thereof.

(g) General note 10(e)(i)(A) is modified by

deleting ‘‘section 504(c)(1)(A) of the Trade

Act of 1974 (19 U.S.C. 2464(c)(1)(A)’’ and by

inserting ‘‘sections 503(c)(2)(A)(i)(I) and

503(c)(2)(A)(ii) of the Trade Act of 1974 (19

U.S.C. 2463(c)(2)(A)(i)(I) and 503(c)(2)(A)(ii)’’

in lieu thereof.

(h) General note 10(f) is modified by

deleting ‘‘section 504(c)(3) of the Trade Act

of 1974 (19 U.S.C. 2464(c)(3)’’ and by

inserting ‘‘section 503(c)(2)(F) of the Trade

Act of 1974 (19 U.S.C. 2463(c)(2)(F)’’ in lieu

thereof.

10. Effective on January 1 in each of the

following years, the enumerated additional

U.S. notes to chapter 4 of the HTS are each

modified by deleting the existing quantitative

limitation set forth therein for the EC 15 and

by inserting in lieu thereof the new

quantitative limitation set forth in this table:

1999 2000

(a) Additional

U.S. note 17

to chapter 4 ... 2,729,000 2,779,000

(b) Additional

U.S. note 18

to chapter 4 ... 1,096,333 1,263,000

(c) Additional

U.S. note 19

to chapter 4 ... 337,333 354,000

(d) Additional

U.S. note 21

to chapter 4 ... 3,965,333 4,082,000

Additional information regarding these

technical modifications can be obtained by

contacting the above-named officials of the

USTR at the number noted above.

[FR Doc. 97–33752 Filed 12–24–97; 8:45 am]

BILLING CODE 3190–01–M

OFFICE OF THE UNITED STATES

TRADE REPRESENTATIVE

Trade Policy Staff Committee; Public

Comments for Multilateral Negotiations

in the World Trade Organization on

Expansion of the List of

Pharmaceutical Products Receiving

Zero Duties

AGENCY: Office of the United States

Trade Representative.

ACTION: Notice and request for

comments.

SUMMARY: The Trade Policy Staff

Committee (TPSC) is requesting written

public comments with respect to

expansion of the list of pharmaceuticals

subject to reciprocal duty elimination by

certain members of the World Trade

Organization (WTO). The specific

information being sought is described in

the background section below.

DATES: Public comments are due by

noon, January 30, 1998.

ADDRESSES: Office of the U.S. Trade

Representative, 600 17th Street, N.W.,

Washington, D.C. 20508.

FOR FURTHER INFORMATION CONTACT:

Barbara Chattin, Director for Tariff

Negotiations, USTR, (202–395–5097).
67684 Federal Register / Vol. 62, No. 248 / Monday, December 29, 1997 / Notices

SUPPLEMENTARY INFORMATION: The

Chairman of the TPSC invites written

comments from the public on the

expansion of the list of pharmaceutical

products receiving duty-free treatment

from certain members of the World

Trade Organization, specifically

additions to the lists of pharmaceutical

active ingredients, prefixes and suffixes

that could be associated with an active

ingredient in order to designate its salt,

ester or hydrate form, or chemical

intermediates intended for the

manufacture of pharmaceutical active

ingredients. Negotiations will take place

during 1998 in the WTO with a view to

adding new pharmaceuticals to the zero

duty list. Any amendments to the list of

pharmaceuticals will be subject to

approval by all participants in the

negotiations.

Background

During the Uruguay Round of

multilateral trade negotiations, the

United States and 16 trading partners

agreed to reciprocal elimination of

duties on approximately 7,000

pharmacuticals on January 1, 1995.

Participants also recognized the need to

periodically update the zero duty list of

pharmaceuticals in order to keep pace

with the dynamic nature of the industry.

As a result of multilateral negotiations

in the World Trade Organization (WTO)

during 1996, the United States and other

participants in the negotiations

eliminated duties on an additional 750

pharmaceuticals on April 1, 1997.

The results of the Uruguay Round

agreement on pharmaceuticals and the

subsequent update by WTO members is

reflected in the Pharmaceutical

Appendix to the Harmonized Tariff

Schedule of the United States (HTSUS).

The HTSUS can be purchased from the

United States Government Printing

Office. An electronic version of HTSUS

can be found at www.usitc.gov. the

Pharmaceutical Appendix of the HTSUS

consists of three tables. Table 1 lists

active pharmaceutical ingredients and

dosage-form products by their

International Nonproprietary Names

(INNs) from the World Heatlh

Organization (WHO). Currently, the

items in Table 1 are drawn from the INN

lists 1–73 of the WHO. Prefixes and

suffixes that can be associated with an

INN in Table 1 are contained in Table

2. Chemical intermediates intended for

the manufacture of pharmaceuticals are

listed in Table 3. Working with

appropriate industry associations and

private sector advisory groups, the

interagency TPSC committee led by

USTR is in the process of preparing

negotiating positions. Comments are

requested for pharmaceutical items

which would be in the interest of the

United States to add to the existing

WTO agreement.

Negotiators will be reviewing the

more recent INN lists (e.g., 74–78) in the

updating exercise. Comments pertaining

to the pharmaceutical active ingredients

covered by INN list 74 and higher need

only provide the INN name and

reference the appropriate WHO list.

Otherwise, the following information

must be supplied for each

pharmaceutical active ingredient or

chemical intermediate to provide the

technical basis for reviewing the

submissions: (1) The precise chemical

name; (2) the Chemical Abstracts

Service (CAS registry number; (3) a

diagram of the molecular structure; and

(4) the six-digit Harmonized System

classification number. Submissions of

chemical intermediates also must

provide the INN and chemical name of

the active ingredient into which it is

incorporated, the CAS number of this

active ingredient, and a diagram of the

molecular structure of this active

ingredient. A suggested format for

presenting this information is attached.

In addition, submissions of chemical

intermediates must demonstrate that the

product meets the following conditions;

(1) The chemical is a solepharmaceutical use intermediate; (2)

some portion of the intermediate is

incorporated in the final active

ingredient molecule, regardless of what

proportion the intermediate represents

in the final molecule of the active

ingredient; and (3) the intermediate is

used in producing an active ingredient

that has reached at least Phase III of

clinical trials of the Food and Drug

Administration (or other national

equivalent). Comments pertaining to the

additions to the list of prefixes or

suffixes for salt, ester or hydrate forms

of an INN active ingredient should state

a rationale for the nomination. Only

comments containing all of the above

information will be considered in

developing U.S. positions for the

negotiations.

Persons submitting written comments

should provide a statement, in twenty

copies, by noon, January 30, 1998 to

Gloria Blue, Executive Secretary, TPSC,

Office of the U.S. Trade Representative,

Room 503, 600 17th Street, NW.,

Washington, D.C. 20508. In addition, a

helpful supplement to the written

statement would be to provide a disk

containing as much of the technical

details of the submission as possible,

either in a spreadsheet format or in a

word processing table format. The disk

should have a label identifying the

software used and the submitter. Nonconfidential information received will

be available for public inspection by

appointment in the USTR Reading

Room, Room 101, Monday through

Friday, 10:00 a.m. to 12:00 noon and

1:00 p.m. to 4:00 p.m. For an

appointment call Brenda Webb on 202–

395–6186. Business confidential

information will be subject to the

requirements of 15 CFR 2003.6. Any

business confidential material must be

clearly marked as such on the cover

letter or page and each succeeding page,

and must be accompanied by a nonconfidential summary thereof.

Frederick L. Montgomery,

Chairman, Trade Policy Staff Committee.

HS code (6-

digit) CAS number

Chemical

name (e.g.,

chemical abstracts index

name

Molecular structure

For all chemical intermediates, the

following information is provided on

the pharmaceutical active ingredient

into which the intermediate is

incorporated.

INN of active

ingredient

CAS number

of active ingredient

Chemical

name of active ingredient

Molecular structure of active ingredient

[FR Doc. 97–33751 Filed 12–24–97; 8:45 am]

BILLING CODE 3190–01–M

DEPARTMENT OF TRANSPORTATION

Office of the Secretary

Reports, Forms and Recordkeeping

Requirements; Agency Information

Collection Activity Under OMB Review

AGENCY: Office of the Secretary, DOT.

ACTION: Notice.

SUMMARY: In accordance with the

Paperwork Reduction Act of 1995 (44

U.S.C. Chapter 3501, et seq.) this notice

announces that the Information

Collection Request (ICR) abstracted

below has been forwarded to the Office

of Management and Budget (OMB) for

review and comment. The ICR describes

the nature of the information collection

and its expected cost and burden. The

Federal Register Notice with a 60-day

comment period soliciting comments on

the following collection of information